Novelix Pharmaceuticals Ltd vs Supriya Lifescience Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Novelix Pharmaceuticals Ltd is ₹ 55.03 as of 30 Apr 15:30 . The P/E Ratio of Novelix Pharmaceuticals Ltd is 0 as of March 2021 .The P/E Ratio of Supriya Lifescience Ltd is 0 as of March 2021 . The Market Cap of Novelix Pharmaceuticals Ltd is ₹ 5.48 crore as of March 2021 .The Market Cap of Supriya Lifescience Ltd is ₹ 0 crore as of March 2021 . The revenue of Novelix Pharmaceuticals Ltd for the Dec '25 is ₹ 48.4 crore as compare to the Sep '25 revenue of ₹ 36.39 crore. This represent the growth of 33% The revenue of Supriya Lifescience Ltd for the Dec '25 is ₹ 209.05 crore as compare to the Sep '25 revenue of ₹ 202.56 crore. This represent the growth of 3.2% The ebitda of Novelix Pharmaceuticals Ltd for the Dec '25 is ₹ 1.31 crore as compare to the Sep '25 ebitda of ₹ 0.73 crore. This represent the growth of 79.45% The ebitda of Supriya Lifescience Ltd for the Dec '25 is ₹ 74.24 crore as compare to the Sep '25 ebitda of ₹ 75.37 crore. This represent the decline of -1.5% The net profit of Novelix Pharmaceuticals Ltd changed from ₹ -0.35 crore to ₹ 1 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Supriya Lifescience Ltd changed from ₹ 44.64 crore to ₹ 49.68 crore over 7 quarters. This represents a CAGR of 6.30% The Dividend Payout of Novelix Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Supriya Lifescience Ltd changed from 3.2 % on March 2021 to 4.28 % on March 2025 . This represents a CAGR of 5.99% over 5 years .

About Novelix Pharmaceuticals Ltd

Trimurthi Limited was formerly incorporated on December 13, 1994 with the name Trimurthi Securities Ltd. The name of the Company thereafter got changed from Trimurthi Securities Ltd to Trimurthi Drugs & Pharmaceuticals Ltd. In September 2006, as per the Scheme of Arrangement, the erstwhile Trimurthi Drugs & Pharmaceuticals Ltd amalgamated with the Company.
Also, the name of the Company was changed to Trimurthi Drugs & Pharmaceuticals Ltd and again to Trimurthi Limited in May, 2016. Initially, the company was engaged in finance and investments in securities.
They ceased their operations due to the high volatility in the markets and voluntarily got de-registered as Non-Banking financial company.
Thereafter, the company explored the possibilities of entering into pharmaceutical and drug industry by way of diversification.

About Supriya Lifescience Ltd

Supriya Lifescience Limited was initially constituted on October 29, 1985, as a 'Partnership Firm under the name M/s Supriya Chemicals'.
The Partnership Firm was last re-constituted pursuant to a Partnership Deed dated November 30, 2007.
Upon the conversion of M/s Supriya Chemicals' the Partnership Firm into a Public Limited Company, the Company got incorporated as Supriya Lifescience Limited' vide certified on March 26, 2008 by the Registrar of Companies, Mumbai. The Company commenced operations in April, 2008.
It is engaged in manufacturing and export of active pharmaceutical ingredients (APIs).
The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients,with a focus on research and development.

FAQs for the comparison of Novelix Pharmaceuticals Ltd and Supriya Lifescience Ltd

Which company has a larger market capitalization, Novelix Pharmaceuticals Ltd or Supriya Lifescience Ltd?

Market cap of Novelix Pharmaceuticals Ltd is 58 Cr while Market cap of Supriya Lifescience Ltd is 5,589 Cr

What are the key factors driving the stock performance of Novelix Pharmaceuticals Ltd and Supriya Lifescience Ltd?

The stock performance of Novelix Pharmaceuticals Ltd and Supriya Lifescience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Novelix Pharmaceuticals Ltd and Supriya Lifescience Ltd?

As of May 4, 2026, the Novelix Pharmaceuticals Ltd stock price is INR ₹40.5. On the other hand, Supriya Lifescience Ltd stock price is INR ₹694.5.

How do dividend payouts of Novelix Pharmaceuticals Ltd and Supriya Lifescience Ltd compare?

To compare the dividend payouts of Novelix Pharmaceuticals Ltd and Supriya Lifescience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.